NCT01724515View on ClinicalTrials.gov

PGC-1 and Mitochondrial Dysfunction in Diabetes

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
DiabetesObese
Interventions
OTHER

Lipid infusion and muscle biopsies

Subjects will undergo a baseline muscle biopsy, a lipid infusion for 5 hours (60 ml/hr), and a muscle biopsy after the lipid infusion.

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER

NCT01724515 - PGC-1 and Mitochondrial Dysfunction in Diabetes | Biotech Hunter | Biotech Hunter